TORONTO -- (MARKET WIRE) -- March 29, 2007 -- Generex Biotechnology Corporation (NASDAQ: GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it will be making two poster presentations at the 4th International Symposium on Diabetes and Pregnancy (http://www.kenes.com/dip07/) to be held in Istanbul, Turkey, March 29 - 31, 2007.
